MyAverix Finance
SA · Healthcare
Biogen Inc (BIIB34)
Drug Manufacturers - General
Biogen Inc (BIIB34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-29, reported market cap is $141.60B, P/E ratio is 20.96, net margin is 13.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BIIB34
Biogen Inc (BIIB34) — FAQ
What is Biogen Inc's market cap?
Biogen Inc (BIIB34) has a reported market cap of $141.60B (data as of 2026-03-29).
What is BIIB34's P/E ratio?
The price-to-earnings (P/E) ratio for Biogen Inc (BIIB34) is 20.96 (data as of 2026-03-29).
Does Biogen Inc pay a dividend?
Dividend yield is not available in the current snapshot for Biogen Inc (BIIB34). Check the MyAverix Finance app for the latest dividend data.
What sector is Biogen Inc in?
Biogen Inc (BIIB34) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is BIIB34 listed on?
BIIB34 is listed on SA.
What is Biogen Inc's net margin?
Biogen Inc (BIIB34) reports a net margin of 13.1% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.